Risk-adapted approach feasible, cost-effective for population-based CRC screening

A risk-adapted approach for population-based colorectal cancer screening was a viable and cost-effective option compared with existing colonoscopy and fecal immunochemical test strategies, according to new research in China.“Current guidelines recommend employing a one-size-fits-all screening strategy (eg, colonoscopy every 10 years, fecal immunochemical test [FIT] every year or every other year) in the targeted population defined solely by age,” Hongda Chen, PhD, of the Medical Research Center at Peking Union Medical College Hospital in Beijing, and colleagues wrote in ClinicalRead More

Related Articles